google +
Versão para impressão

Notícias (Substâncias ilícitas)

This section on health in the EU has been created as a trustworthy gateway to a wide range of information and data on health-related issues and activities at both European, national and international level. The content is produced by the European Commission, the Member States of the EU and the European Economic Area (EEA), plus EU candidate countries; by international organisations; and by pan-European non-governmental organisations in the area of public health.

Just published: The ESPAD validity study in four countries in 2013

Assessing the validity of the information that has been collected is a relevant issue in any study. After the publication of the 2011 ESPAD report and in the view of preparations for the 2015 survey,[...]

Just published: FInal report on study CT.97.EP.13

The aim of this report was to provide a detailed review of epidemiological studies on drug-related emergencies implemented recently (10 years) in the European Union, and to synthesise information gen[...]

Just published: Drugnet Europe 91

In this issue: New technical report on estimating trends in injecting drug use | EMCDDA: 20 years of monitoring | Memorandum of Understanding with Armenia | EMCDDA launches IPA 5 project with the Wes[...]

Just published: Alternatives to punishment for drug-using offenders

Based on the options provided by the international drug control legal framework, this paper considers the rehabilitative measures of treating, educating or reintegrating drug users as alternatives or[...]

Just published: Budget 2015

The EMCDDA receives stable funding under Commission budget line B3-441 of the general budget of the European Union. Each year, a preliminary draft budget is presented by the Centre's Director to the [...]

Just published: EMCDDA-Europol 2014 Annual Report

This report presents the key activities performed by the EMCDDA and Europol in 2014, with details on all the relevant activities in support of the implementation of Council Decision 2005/387/JHA on t[...]

Just published: New psychoactive substances in Europe: Innovative legal responses

This short report provides an overview of how European countries are developing innovative legal responses to the challenges presented to public health and drug policy by the rapidly evolving market [...]

Just published: Drugs policy and the city in Europe

Illicit drug problems and responses and the different forms they can take in the city environment are explored in this paper. It addresses four areas: urban spaces and drug use, responses to city-lev[...]

Just published: Annual accounts 2014

In accordance with Article 76 of the Financial Regulation applicable to the EMCDDA, the accounts of the EMCDDA shall comprise: 'The financial statements of the EMCDDA and the reports on implementatio[...]

Just published: A year in review 2014

The series `A year in review' contains the essence of the EMCDDA's General Report of Activities. It is designed to provide interested audiences with a brief, four-page summary of the agency's achieve[...]

Just published: Drugnet Europe 90

In this issue: European Drug Report 2015 highlights | Growing importance of effective treatment for cannabis use | Lisbon Addictions 2015 | European drugs summer school 2015 | First overview of the d[...]

Psychoactive substances ban will 'end brain research' in Britain, experts warn

Drug researchers have warned that a bill to ban the sale of all psychoactive substances will be disastrous for brain research in the UK.[...]

Annual meeting of the Reitox Early Warning System network

The latest developments in monitoring and responding to new psychoactive substances (NPS/'new drugs') were discussed at the 15th annual meeting of the Reitox Early Warning System (EWS) network, held [...]

European Drug Report 2015 - published by the EMCDDA

First European conference on addictive behaviours and dependencies 26 June 2010 - International day against drug abuse and illicit trafficking 26 June: International day against drug abuse and illic[...]

Just published: European Drug Report 2015

Changing dynamics in the heroin market, the latest implications of cannabis use and new features and dimensions of the stimulant and `new drugs' scene are among the issues highlighted in the European[...]

EMCDDA explores new dynamics and dimensions of Europe’s drugs problem

Changing dynamics in the heroin market, the latest implications of cannabis use and new features and dimensions of the stimulant and `new drugs' scene, are among the issues highlighted by the EU drug[...]

Just published: EDR 2015: promotional brochure

This brochure provides an overview of the 2015 European Drug Report package and includes brief summaries of the four new additions to the Perspectives on drugs (PODs) series.[...]

Just published: Austria

Commissioned each year by the EMCDDA and produced by the national focal points of the Reitox network, the National reports draw an overall picture of the drug phenomenon at national level in each EU [...]

Psychoactive substances ban will 'end brain research' in Britain, experts warn

Drug researchers have warned that a bill to ban the sale of all psychoactive substances will be disastrous for brain research in the UK.[...]

EMCDDA underlines growing importance of effective treatment for cannabis use

Providing effective treatment for those with cannabis use disorders is likely to become a matter of growing importance in European drug policy. This is according to the EU drugs agency (EMCDDA) today[...]

Coming soon: European Drug Report 2015

(Lisbon, 15.04.2015) What are the latest drug market trends and what are the factors driving them? What are the most recent developments in drug prevention, treatment and policy? How many new drugs w[...]

New psychoactive substances in Europe - Just Published - EU Bookshop

An update from the EU Early Warning System, March 2015[...]

Parkinson's Disease Severity and Use of Dopaminergic Medications

The outcomes measured at the beginning of the study showed lower disease burden for participants on initial DA monotherapy compared to those taking combined LD and DA therapy after controlling for ag[...]

Just published: Pregnancy and opioid use: strategies for treatment

Illicit opioid consumption during pregnancy brings with it the risk of an increase in obstetric complications for the mother and a range of potential dangers for the child, both before and after birt[...]


The European Commission is solely responsible for information present on EU-level websites, information present in the Portal originated by the Commission. National-level information is provided by the Member States concerned and Member States are solely responsible for the accuracy of the information. Likewise, the European Commission is not responsible for information on non-governmental organisations and international organisations websites. The European Union is committed to user privacy. Read more concerning the Legal Notice.
Further questions can be answered through the Contact page. The Health-EU portal supports principles and measures to increase the credibility of information on the net. It complies with the HONcode standard for trustworthy health information: verify here.